ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,071 | -33.5% | 25,805 | -0.4% | 0.01% | -30.0% |
| Q2 2023 | $4,616 | +6.2% | 25,905 | -1.7% | 0.01% | 0.0% |
| Q1 2023 | $4,347 | +4.0% | 26,351 | -0.8% | 0.01% | 0.0% |
| Q4 2022 | $4,181 | -99.9% | 26,551 | -0.4% | 0.01% | 0.0% |
| Q3 2022 | $4,014,000 | -12.3% | 26,651 | -4.3% | 0.01% | -9.1% |
| Q2 2022 | $4,578,000 | -26.2% | 27,851 | 0.0% | 0.01% | -15.4% |
| Q1 2022 | $6,201,000 | -6.2% | 27,851 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $6,610,000 | +12.9% | 27,851 | +11.0% | 0.01% | +8.3% |
| Q3 2021 | $5,856,000 | +21.4% | 25,090 | +7.1% | 0.01% | +20.0% |
| Q2 2021 | $4,823,000 | +0.2% | 23,434 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $4,814,000 | -4.2% | 23,434 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $5,026,000 | +22.0% | 23,434 | +4.0% | 0.01% | +10.0% |
| Q3 2020 | $4,118,000 | -0.8% | 22,534 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $4,153,000 | -8.7% | 22,534 | 0.0% | 0.01% | -28.6% |
| Q1 2020 | $4,547,000 | +7.8% | 22,534 | 0.0% | 0.01% | +40.0% |
| Q4 2019 | $4,217,000 | +18.3% | 22,534 | +0.9% | 0.01% | +11.1% |
| Q3 2019 | $3,565,000 | -37.8% | 22,334 | -1.8% | 0.01% | -40.0% |
| Q2 2019 | $5,728,000 | -3.3% | 22,739 | -8.1% | 0.02% | 0.0% |
| Q1 2019 | $5,921,000 | +4.2% | 24,739 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $5,681,000 | -18.5% | 24,739 | +0.4% | 0.02% | 0.0% |
| Q3 2018 | $6,967,000 | +6.2% | 24,639 | +10.3% | 0.02% | 0.0% |
| Q2 2018 | $6,558,000 | +16.3% | 22,334 | 0.0% | 0.02% | +14.3% |
| Q1 2018 | $5,637,000 | -8.4% | 22,334 | -21.6% | 0.01% | -6.7% |
| Q4 2017 | $6,157,000 | +16.3% | 28,505 | +0.0% | 0.02% | +15.4% |
| Q3 2017 | $5,296,000 | +0.7% | 28,496 | -6.6% | 0.01% | 0.0% |
| Q2 2017 | $5,261,000 | +12.6% | 30,496 | -0.3% | 0.01% | +8.3% |
| Q1 2017 | $4,672,000 | +3.6% | 30,596 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $4,508,000 | +11.5% | 30,596 | -4.4% | 0.01% | +9.1% |
| Q3 2016 | $4,044,000 | +11.7% | 31,996 | -0.3% | 0.01% | +10.0% |
| Q2 2016 | $3,619,000 | +8.3% | 32,096 | 0.0% | 0.01% | +11.1% |
| Q1 2016 | $3,341,000 | -7.4% | 32,096 | +0.3% | 0.01% | -10.0% |
| Q4 2015 | $3,609,000 | +8.4% | 31,996 | +5.3% | 0.01% | +11.1% |
| Q3 2015 | $3,328,000 | +14.5% | 30,396 | +0.1% | 0.01% | +12.5% |
| Q2 2015 | $2,906,000 | +8.4% | 30,377 | +5.6% | 0.01% | +14.3% |
| Q1 2015 | $2,680,000 | -42.3% | 28,777 | -49.3% | 0.01% | +16.7% |
| Q4 2014 | $4,648,000 | +157.1% | 56,754 | +101.4% | 0.01% | +20.0% |
| Q3 2014 | $1,808,000 | +4.3% | 28,177 | -1.1% | 0.01% | 0.0% |
| Q2 2014 | $1,733,000 | -0.9% | 28,493 | -2.4% | 0.01% | 0.0% |
| Q1 2014 | $1,748,000 | -7.0% | 29,193 | -1.0% | 0.01% | 0.0% |
| Q4 2013 | $1,879,000 | -7.5% | 29,493 | -1.3% | 0.01% | -16.7% |
| Q3 2013 | $2,031,000 | -7.6% | 29,893 | -2.0% | 0.01% | 0.0% |
| Q2 2013 | $2,197,000 | – | 30,493 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |